AMSBIO reports that its extensive range of FDA tissue microarrays reliably enhances tissue cross-reactivity (TCR) and other target validation studies. These high-quality tissue microarrays (TMAs) ...
With respect to assay development, quality assurance and, ultimately, clinical adoption, the primary subject of this review, these advantages are critical. Implicit with these advantages, TMAs enable ...
CD Biosciences Announces Advanced Multiple Organ System Tissue Microarrays For Histology Researchers
(MENAFN- ForPressRelease) CD BioSciences, a US-based biotechnology company focusing on the development of imaging technologies, is proud to introduce its new Multiple Organ System Tissue Microarrays ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback